Literature DB >> 18299736

Probiotic products in Canada with clinical evidence: what can gastroenterologists recommend?

G Reid1, K Anukam, T Koyama.   

Abstract

Probiotics, defined as 'live microorganisms, which when administered in adequate amounts, confer a health benefit on the host', are finally becoming an option for gastroenterologists in Canada, after being available for many years in Japan, Europe and the United States of America. Unfortunately, Health Canada and the US Food and Drug Administration have not controlled the use of the term 'probiotic' or put into place United Nations and World Health Organization guidelines. The net result is that a host of products called 'probiotics' are available but are not truly probiotic. The aim of the present review was to discuss the rationale for probiotics in gastroenterology, and specifically examine which products are options for physicians in Canada, and which ones patients might be using. It is hoped that by clarifying what probiotics are, and the strengths and limitations of their use, specialists will be better placed to make recommendations on the role of these products in patient care. In due course, more clinically documented probiotics will emerge, some with therapeutic effects based on a better understanding of disease processes.

Entities:  

Mesh:

Year:  2008        PMID: 18299736      PMCID: PMC2659138          DOI: 10.1155/2008/843892

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  69 in total

Review 1.  New scientific paradigms for probiotics and prebiotics.

Authors:  Gregor Reid; M E Sanders; H Rex Gaskins; Glenn R Gibson; Annick Mercenier; Robert Rastall; Marcel Roberfroid; Ian Rowland; Christine Cherbut; Todd R Klaenhammer
Journal:  J Clin Gastroenterol       Date:  2003-08       Impact factor: 3.062

Review 2.  Bacteria in the pathogenesis of inflammatory bowel disease.

Authors:  Sreedhar Subramanian; Barry James Campbell; Jonathan Michael Rhodes
Journal:  Curr Opin Infect Dis       Date:  2006-10       Impact factor: 4.915

3.  Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis.

Authors:  Uri Gophna; Katrin Sommerfeld; Sharon Gophna; W Ford Doolittle; Sander J O Veldhuyzen van Zanten
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

4.  Diarrhoea associated with antibiotic use.

Authors:  Lynne V McFarland
Journal:  BMJ       Date:  2007-07-14

5.  Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea.

Authors:  A G Billoo; M A Memon; S A Khaskheli; G Murtaza; Khalid Iqbal; M Saeed Shekhani; Ahson Q Siddiqi
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

Review 6.  Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.

Authors:  E M M Quigley; B Flourie
Journal:  Neurogastroenterol Motil       Date:  2007-03       Impact factor: 3.598

7.  Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease.

Authors:  Shadi Sepehri; Roman Kotlowski; Charles N Bernstein; Denis O Krause
Journal:  Inflamm Bowel Dis       Date:  2007-06       Impact factor: 5.325

8.  Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.

Authors:  Christel Rousseaux; Xavier Thuru; Agathe Gelot; Nicolas Barnich; Christel Neut; Laurent Dubuquoy; Caroline Dubuquoy; Emilie Merour; Karen Geboes; Mathias Chamaillard; Arthur Ouwehand; Greg Leyer; Didier Carcano; Jean-Frédéric Colombel; Denis Ardid; Pierre Desreumaux
Journal:  Nat Med       Date:  2006-12-10       Impact factor: 53.440

9.  Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis.

Authors:  L-H Wang; X-C Fang; G-Z Pan
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

10.  Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients.

Authors:  M Lorea Baroja; P V Kirjavainen; S Hekmat; G Reid
Journal:  Clin Exp Immunol       Date:  2007-06-22       Impact factor: 4.330

View more
  3 in total

Review 1.  Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives.

Authors:  Elaine Dempsey; Sinéad C Corr
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

2.  Probiotics in the arabian gulf region.

Authors:  Abiola C Senok
Journal:  Food Nutr Res       Date:  2009-03-04       Impact factor: 3.894

3.  Addition of clidinium-C to the 14-day proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication.

Authors:  Mohammadreza Seyyedmajidi; Saba Homapoor; Elahe Zanganeh; Mohammad Dadjou; Shahab Eskandari Nejad; Mohammad Hadi Tajik Galayeri; Jamshid Vafaeimanesh
Journal:  Caspian J Intern Med       Date:  2016
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.